Education

• Medical Doctor, Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina 1998-2004
• Internship, Internal Medicine, Department of Medicine, FLENI Institute, Buenos Aires, Argentina 2005-2006
• Residency, Neurology, Department of Neurology, FLENI Institute, Buenos Aires, Argentina 2006-2009
• Neurology Specialist, School of Medicine, Universidad de Buenos Aires, Buenos Aires, Argentina 2006-2009
• Neuro-Oncology Fellow, Department of Neurology Memorial-Sloan Kettering Cancer Center New York, NY 2011-2014

Continuing Medical Education:

• Clinical Research Methodology Curriculum Memorial Sloan-Kettering Cancer Center. New York, New York. 2011-2012
• Communications Skills Comskil Laboratory Memorial Sloan-Kettering Cancer Center. New York, New York. 2011-2012

Profile

Dr. Macarena de la Fuente is a neuro-oncologist who specializes in the care of patients with primary brain tumors. She obtained her medical degree from Universidad Nacional de La Plata, Buenos Aires, Argentina in 2004, and subsequently completed a neurology residency at FLENI Institute, Buenos Aires, Argentina. Dr. de la Fuente obtained further subspecialty training in neuro oncology at the Memorial-Sloan Kettering Cancer Center, New York.

Dr. de la Fuente conducts clinical trials in an effort to develop innovative, more effective treatments for brain tumors in both the upfront and recurrent settings. Her research interest focuses on IDH-mutant gliomas, specifically investigating radiographic biomarkers for these tumors.

Research Interest

IDH-mutant gliomas, specifically investigating radiographic biomarkers for these tumors.

Professional Activities:

Current Positions

• 2014- Assistant Professor, Department of Neurology and  Sylvester Comprehensive Cancer Center University of Miami, Miami, FL  
• 2014-  Consultant, Department of Neurology Memorial Sloan-Kettering Cancer Center New York, NY

Professional Experience

• Chief Resident, Neurology, Department of Neurology  2009-2010
• FLENI Institute, Buenos Aires, Argentina Assistant Professor of Neurology, Department of Neurology FLENI Institute, Buenos Aires, Argentina  2010-2011

Hospital Appointments

• Assistant Attending, Department of Neurology, FLENI Institute, Buenos Aires, Argentina 2010-2011

Professional Licenses And Certification

• Argentine Republic, Ministry of Health, Medical License, License Number 116956 - 2005 Argentine Republic, Ministry of Health, Specialist in Neurology, certification  Number 32310 – 2009
• ECFMG certificate ID 0-787-138-7
• New York State Medical Limited Permit, Permit # P81859, Issue Date: 09/14/2011 New York State Medical License, License Number 270263, Issue Date: 05/17/2013 DEA number FD3945029
• NPI number 1952686388
• Florida Medical License, License Number ME 120369

Professional And Society Memberships

• American Academy of Neurology                                                       2010-current
• Society for Neuro-Oncology                                                               2012-current
• American Society of Clinical Oncology                                              2013-current

Teaching Positions

• 2000-2004 Teaching Assistant, Department of Anatomy Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina. Teaching Assistant, Department of Neurology 
• 2006-2011 Universidad de Buenos Aires, Buenos Aires, Buenos Aires. Teaching Assistant, Department of Neurology
• 2006-2010 Universidad Austral, Buenos Aires, Buenos Aires. RSA teaching sessions, Department of Neurology
• 2011-2014 Memorial Sloan Kettering, New York, NY

Honors and Awards

Publications

Bibliography:

Articles:

1. De la Fuente MI, et al. Stroke as complication of intravenous immunoglobulin treatment.
   Arch Neurol Neurocir Neuropsiquiatr.2006:12(2);48-51.
2. Falcone GJ, de la Fuente MI, Paoli N, Arakaki N, Cammarota A. Limbic encephalitis and glioblastoma: causal or temporal association? Arch Neurol Neurocir Neuropsiquiatr. 2008:15(1);47-49.
3. Lautre A, de la Fuente MI, et al. Eaton-Lambert Syndrome: diagnostic difficulties in 5 patients. Arch Neurol Neurocir Neuropsiquiatr.2009:17(1);12-15.
4. Bruno V, Fernandez Suarez M, de la Fuente MI, et al. Guillain Barre syndrome and central nervous system vasculitis as ulcerative colitis initial symptoms. Arch Neurol Neurocir Neuropsiquiatr.2009:17(2);60-64.
5. Barroso F, de la Fuente MI. Compound muscle action potential temporal dispersion during hypokalemia. Muscle and Nerve. 2009 Oct;40(4):662-3.
6. De la Fuente MI, DeAngelis LM. The role of ventriculo-peritoneal shunting in patients with supratentorial glioma. Annals Clinical and Translational Neurology 2014; 1(1):45-48.
7. De la Fuente MI, Kaley T. Whole brain radiotherapy in patients with brain metastases from melanoma. CNS Oncology. In press.

Presentations/Abstracts:

1. De la Fuente MI et al. Central Nervous System Vasculitis related to Streptococcus pneumoniae sepsis. Argentine Meeting of Internal Medicine. November 2005.
2. De la Fuente MI et al. Stroke as complication of intravenous immunoglobulin treatment. Argentine Meeting of Neurology. November 2006.
3. De la Fuente MI et al. Autonomic crisis in Riley-Day syndrome. Argentine Meeting of Neurology. November 2007.
4. De la Fuente MI et al. Adult onset leukodystrophies with peripheral nervous system involvement. Argentine Meeting of Neurology. November 2007.
5. Cavanagh S, de la Fuente MI, Brand P, Cammarota A, Nogués M.Paraneoplastic cerebellar degeneration and ovarian teratoma. Argentine Meeting of Neurology. 2007.
6. Fernandez Suarez M, Gaitan MI, de la Fuente MI, Muggeri A, Nogues M.Infrequent etiologies in leptomeningeal carcinomatosis.  Argentine Meeting of Neurology. 2008
7. De la Fuente MI, Amaya M, Diez B, et al. Primary Central Nervous System Lymphoma in Immunocompetent Patients: Experience in a Neurological Centre in Argentina. Neurology 2008; 70(suppl 1): A161. Abstract.
8. Paoli N, Falcone G, De la Fuente MI, et al. Thrombotic Cerebrovascular Disease Related to Hormone Therapy in Women. Neurology 2008; 70(suppl 1): A159. Abstract.
9. De la Fuente MI, Cavanagh S, Sevlever G, et al. Non Metastatic Medulloblastoma in Patients over 16 Years of Age: Experience in a Neurological Centre in Argentina. Neurology 2009; 72(suppl 3): A33. Abstract.
10. De la Fuente MI, Marengo R, Nogues M, et al. Esthesioneuroblastoma: Clinical and Survival Analysis at a Single Institution in Argentina. Neurology 2010; 74(suppl 2): A533. Abstract.
11. Moschini J, Meli F, Goicochea M, De la Fuente MI. Clinical and Radiological Features of Reversible Cerebral Vasoconstriction Syndrome. Neurology 2010; 74(suppl 2): A143. Abstract.
12. Schottlaender L, Alderuccio J, De la Fuente MI et al. Survival-related factors in 82 patients with glioblastoma. Experience at a single-centre in Argentina. J Neurol 2010 257
    (Suppl 1):S152–S153.
13. De la Fuente MI, Schottlaender L, Muggeri A, Nogues M, Diez B. Primary Central Nervous System Lymphoma in immunocompetent patients: a 15-year experience at a Single Neurological Centre in Argentina. J Neurol 2010 257 (Suppl 1):S154.
14. De la Fuente MI, Kaley T. Whole brain radiotherapy in patients with brain metastases from melanoma. Neuro Oncol 2012 14 (suppl 6): vi71.
15. De la Fuente MI, DeAngelis LM. The role of ventriculo-peritoneal shunting in patients with supratentorial glioma. Neurology 2013 80:IN10-1.009.
16. De la Fuente, MI, DeAngelis LM, Omuro A. Unconfirmed complete response (CRu) in patients with primary central nervous system lymphoma (PCNSL).  Neuro Oncol 2013 15 (suppl 3): NO038.